Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue

mBio

Volumn 3, Issue 3, 2012, Pages

  Palmer, Samantha G ^a   Porotto, Matteo ^a   Palermo, Laura M ^a   Cunha, Luis F ^b   Greengard, Olga ^a,c   Moscona, Anne ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; VIRUS FUSION PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RESPIRATORY EPITHELIUM; TEMPERATURE SENSITIVITY; VIRAL PHENOMENA AND FUNCTIONS; VIROGENESIS; VIRUS ADAPTATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS FUSION; VIRUS IDENTIFICATION; VIRUS MUTATION; VIRUS SURVIVAL;

HUMAN PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS;

EID: 84863422771     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00137-12     Document Type: Article

References (32)

1. Henrickson KJ, Hoover S, Kehl KS, Hua W. 2004. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr. Infect. Dis. J. 23:S11-S18.
2. Moscona A. 2005. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J. Clin. Invest. 115: 1688-1698.
3. Srinivasan A, et al. 2011. Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 17:1520-1527.
4. Yang HT, et al. 2011. Identification of a natural human serotype 3 parainfluenza virus. Virol. J. 8:58.
5. Farzan SF, et al. 2011. Premature activation of the Paramyxovirus fusion Protein before target cell attachment with corruption of the viral fusion machinery. J. Biol. Chem. 286:37945-37954.
6. Moscona A, Peluso RW. 1993. Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity. J. Virol. 67:6463-6468.
7. Porotto M, Fornabaio M, Kellogg GE, Moscona A. 2007. A second receptor binding site on human parainfluenza virus type 3 hemagglutininneuraminidase contributes to activation of the fusion mechanism. J. Virol. 81:3216-3228.
8. Porotto M, et al. 2004. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites. J. Virol. 78:13911-13919.
9. Palermo LM, et al. 2009. Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity. J. Virol. 83:6900-6908.
10. Porotto M, Palmer SG, Palermo LM, Moscona A. 2012. Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry. J. Biol. Chem. 287:778-793.
11. Zhang L, et al. 2005. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J. Virol. 79:1113-1124.
12. Moscona A, et al. 2010. A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo. J. Infect. Dis. 202:234-241.
13. Palermo LM, Porotto M, Greengard O, Moscona A. 2007. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II. J. Virol. 81: 9152-9161.
14. Connolly SA, Leser GP, Jardetzky TS, Lamb RA. 2009. Bimolecular complementation of paramyxovirus fusion and hemagglutininneuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J. Virol. 83:10857-10868.
15. Connolly SA, Leser GP, Yin HS, Jardetzky TS, Lamb RA. 2006. Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy. Proc. Natl. Acad. Sci. U. S. A. 103:17903-17908.
16. Lawrence MC, et al. 2004. Structure of the haemagglutininneuraminidase from human parainfluenza virus type III. J. Mol. Biol. 335:1343-1357.
17. Yin HS, Paterson RG, Wen X, Lamb RA, Jardetzky TS. 2005. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc. Natl. Acad. Sci. U. S. A. 102:9288-9293.
18. Yin HS, Wen X, Paterson RG, Lamb RA, Jardetzky TS. 2006. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439:38-44.
19. Lee JK, et al. 2008. Functional interaction between paramyxovirus fusion and attachment proteins. J. Biol. Chem. 283:16561-16572.
20. Schowalter RM, Chang A, Robach JG, Buchholz UJ, Dutch RE. 2009. Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry. J. Virol. 83:1511-1522.
21. Smith EC, Dutch RE. 2010. Side chain packing below the fusion peptide strongly modulates triggering of the Hendra virus F protein. J. Virol. 84: 10928-10932.
22. McLellan JS, Yang Y, Graham BS, Kwong PD. 2011. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J. Virol. 85:7788-7796.
23. Swanson KA, et al. 2011. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc. Natl. Acad. Sci. U. S. A. 108:9619-9624.
24. Murrell MT, Greengard O, Porotto M, Poltoratskaia N, Moscona A. 2001.Asingle amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity. J. Virol. 75:6310-6320.
25. Murrell M, Porotto M, Weber T, Greengard O, Moscona A. 2003. Mutations in human parainfluenza virus type 3 hemagglutininneuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (zanamivir). J. Virol. 77:309-317.
26. Jorgensen WL. 2004. The many roles of computation in drug discovery. Science 303:1813-1818.
27. Jorgensen WL, Maxwell DS, Tirado-Rives J. 1996. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. 118:11225-11236.
28. Humphrey W, Dalke A, Schulten K. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:33-38, 27-38.
29. Phillips JC, et al. 2005. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26:1781-1802.
30. Latger-Cannard V, et al. 2000. [Use of standard for quantitation of adhesion of polynuclear neutrophils by flow cytometry]. Ann. Biol. Clin. (Paris) 58:337-343.
31. Smith KB, Ellis SA. 1999. Standardisation of a procedure for quantifying surface antigens by indirect immunofluorescence. J. Immunol. Methods 228:29-36.
32. Moosmann P, Rusconi S. 1996. Alpha complementation of LacZ in mammalian cells. Nucleic Acids Res. 24:1171-1172.